Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by Everence Capital Management Inc.

Everence Capital Management Inc. lowered its position in Henry Schein, Inc. (NASDAQ:HSIC) by 30.4% during the fourth quarter, HoldingsChannel.com reports. The fund owned 3,830 shares of the company’s stock after selling 1,670 shares during the quarter. Everence Capital Management Inc.’s holdings in Henry Schein were worth $265,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of HSIC. GAMMA Investing LLC grew its holdings in Henry Schein by 38.1% in the fourth quarter. GAMMA Investing LLC now owns 2,858 shares of the company’s stock valued at $198,000 after purchasing an additional 789 shares during the last quarter. Versant Capital Management Inc boosted its position in shares of Henry Schein by 274.6% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $32,000 after buying an additional 335 shares in the last quarter. Principal Financial Group Inc. grew its stake in Henry Schein by 2.1% in the 3rd quarter. Principal Financial Group Inc. now owns 145,835 shares of the company’s stock valued at $10,631,000 after acquiring an additional 3,037 shares during the last quarter. Franklin Resources Inc. increased its holdings in Henry Schein by 14.0% during the 3rd quarter. Franklin Resources Inc. now owns 37,637 shares of the company’s stock valued at $2,673,000 after acquiring an additional 4,621 shares in the last quarter. Finally, Tidal Investments LLC lifted its holdings in shares of Henry Schein by 54.9% in the third quarter. Tidal Investments LLC now owns 13,942 shares of the company’s stock valued at $1,016,000 after purchasing an additional 4,939 shares in the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

HSIC has been the subject of a number of recent research reports. Mizuho started coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price objective for the company. Barrington Research reissued an “outperform” rating and issued a $82.00 target price on shares of Henry Schein in a research note on Wednesday, November 6th. Evercore ISI raised their price target on shares of Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 8th. Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and boosted their price objective for the company from $69.00 to $84.00 in a research report on Monday. Finally, StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Seven research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $79.40.

Insider Transactions at Henry Schein

In related news, COO Michael S. Ettinger sold 12,240 shares of Henry Schein stock in a transaction on Monday, November 18th. The shares were sold at an average price of $75.00, for a total transaction of $918,000.00. Following the transaction, the chief operating officer now owns 87,706 shares in the company, valued at approximately $6,577,950. The trade was a 12.25 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 1.14% of the company’s stock.

Henry Schein Price Performance

Shares of Henry Schein stock opened at $71.67 on Wednesday. The business’s fifty day moving average price is $72.13 and its 200 day moving average price is $70.37. Henry Schein, Inc. has a twelve month low of $63.67 and a twelve month high of $82.63. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The stock has a market capitalization of $8.94 billion, a P/E ratio of 29.49, a PEG ratio of 2.30 and a beta of 0.89.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.17 by $0.05. The business had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company’s revenue was up .4% compared to the same quarter last year. During the same period in the previous year, the company posted $1.32 EPS. As a group, research analysts anticipate that Henry Schein, Inc. will post 4.78 earnings per share for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.